Your browser doesn't support javascript.
loading
Structure-Stability Relationship of NLRP3 Inflammasome-Inhibiting Sulfonylureas.
Keuler, Tim; Ferber, Dominic; Marleaux, Michael; Geyer, Matthias; Gütschow, Michael.
Afiliação
  • Keuler T; Pharmaceutical Institute, University of Bonn, 53121 Bonn, Germany.
  • Ferber D; Pharmaceutical Institute, University of Bonn, 53121 Bonn, Germany.
  • Marleaux M; Institute of Structural Biology, University of Bonn, 53127 Bonn, Germany.
  • Geyer M; Institute of Structural Biology, University of Bonn, 53127 Bonn, Germany.
  • Gütschow M; Pharmaceutical Institute, University of Bonn, 53121 Bonn, Germany.
ACS Omega ; 7(9): 8158-8162, 2022 Mar 08.
Article em En | MEDLINE | ID: mdl-35284735
ABSTRACT
In recent drug development efforts, particular emphasis has been devoted to the chemical interference with the NLRP3 inflammasome. A series of 12 tailored sulfonylureas was designed, prepared through convergent syntheses with a final sodium hydride-promoted reaction of isocyanates and sulfonamides, and subjected to a systematic, high-performance liquid chromatography-based survey of the chemical stability, a critical issue of sulfonylureas in terms of preparation, storage, and application. NLRP3 binding was determined by surface plasmon resonance spectroscopy. Sulfonylurea 2 was identified to be equipotent and similarly stable compared to the prototypical NLRP3 inhibitor MCC950.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article